NBPF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.177000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.195000E-01
Normal-vs-Stage2
1.720350E-01
Normal-vs-Stage3
1.019540E-02
Normal-vs-Stage4
8.893600E-01
Stage1-vs-Stage2
5.815600E-01
Stage1-vs-Stage3
4.080100E-02
Stage1-vs-Stage4
4.259800E-01
Stage2-vs-Stage3
8.628200E-04
Stage2-vs-Stage4
3.703000E-01
Stage3-vs-Stage4
1.345980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.937640E-01
Normal-vs-AfricanAmerican
8.145400E-01
Normal-vs-Asian
2.262600E-01
Caucasian-vs-AfricanAmerican
1.565030E-01
Caucasian-vs-Asian
8.904400E-01
AfricanAmerican-vs-Asian
2.329800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.801180E-01
Normal-vs-Female
2.836600E-01
Male-vs-Female
6.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.855400E-01
Normal-vs-Age(41-60Yrs)
5.965200E-01
Normal-vs-Age(61-80Yrs)
1.121400E-01
Normal-vs-Age(81-100Yrs)
6.738000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.717400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.202800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.693000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.198300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.800500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.633000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.189600E-02
Normal-vs-Daily Drinker
3.618100E-02
Normal-vs-Weekly Drinker
2.110600E-01
Normal-vs-Occasional Drinker
6.707400E-01
Normal-vs-Social Drinker
5.870800E-01
Non Drinker-vs-Daily Drinker
4.739000E-01
Non Drinker-vs-Weekly Drinker
4.312200E-01
Non Drinker-vs-Occasional Drinker
7.357800E-02
Non Drinker-vs-Social Drinker
7.314000E-02
Daily Drinker-vs-Weekly Drinker
1.961990E-01
Daily Drinker-vs-Occasional Drinker
2.221700E-02
Daily Drinker-vs-Social Drinker
3.442200E-02
Weekly Drinker-vs-Occasional Drinker
3.175600E-01
Weekly Drinker-vs-Social Drinker
3.960200E-01
Occasional Drinker-vs-Social Drinker
8.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.878800E-01
Normal-vs-Grade 2
5.730600E-01
Normal-vs-Grade 3
8.530600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.791000E-01
Grade 1-vs-Grade 3
4.499200E-01
Grade 1-vs-Grade 4
5.878800E-01
Grade 2-vs-Grade 3
7.196800E-01
Grade 2-vs-Grade 4
5.730600E-01
Grade 3-vs-Grade 4
8.530600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.309570E-01
Normal-vs-NonDiabetic
1.714980E-01
Diabetic-vs-NonDiabetic
8.826800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.590000E-02
Normal-vs-NoPancreatitis
1.904550E-01
Pancreatitis-vs-NoPancreatitis
8.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.120000E-01
Normal-vs-N1
1.740180E-01
N0-vs-N1
7.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.611400E-01
Normal-vs-TP53-NonMutant
4.740000E-01
TP53-Mutant-vs-TP53-NonMutant
4.107200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
